The move by Great Britain to step away from the European Union may be sending chills of uncertainty to many
Breaking News
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
Last year, Cardiff, U.K.-based Verona secured £44.7 million ($65.6 million) from big-name investors on both sides of the Atlantic for
Medical device firm Mainstay Medical said operating expenses rose by $3.9 million for 2016 to $16.8 million as Mainstay kicked
Researchers at Trinity College Dublin have discovered a way to prevent bacteria from growing on medical devices that are implanted
Newron, an Italian biotech focused on CNS diseases, is on a roll. The latest win? FDA approval of its Parkinson’s
Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany
Eurofins Scientific announced on March 20, 2017 that it will be establishing a new pharmaceutical chemistry and microbiology facility in
Shire has secured label expansion approval from the European Commission for its hereditary angioedema therapy Cinryze. The European Commission (EC)
Cerenis therapeutic’s lead candidate CER-001 has failed Phase II for the treatment of patients with post-acute coronary syndrome (ACS). The
Irish hospital software group Oneview Healthcare has secured another contract in the United States. The listed company will roll out
Debiopharm International, a Swiss-based company, part of Debiopharm Group, announced that triptorelin 6-month formulation (Decapeptyl and Pamorelin 22.5 mg) received
Natoli Engineering Company, Inc. is expanding its European presence by launching its newest business division, Natoli International, and with that,
Novartis has received FDA approval for Kisqali, a first-line treatment for breast cancer originally developed by the British biotech Astex
Scientists from the University of Cambridge have determined the first 3D structures of mammalian genomes from individual cells. For the
General practice in Scotland will benefit from an extra £250 million a year by 2021 under wider plans to raise
MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced
Representatives from the European Medicines Agency (EMA) met with medicines regulators from Africa last week to discuss how to improve
Cambridge Academy of Therapeutic Sciences aims to create world-leading industry-academia collaborations with new initiative The Cambridge Academy of Therapeutic Sciences
Advertisements
